Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli ...

Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...

This little-known artificial intelligence growth stock is backed by chipmaker Nvidia and recently jumped nearly 24% in a ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

The boss of drugmaker AstraZeneca was handed a pay package worth nearly £15m last year, new company accounts reveal.

Astrazeneca is too big and complex to base its CEO's pay on the rest of the FTSE index, according to the chair of its ...

Pascal Soriot (pictured) topped up his basic salary of £1.8m with extras that included a bonus of £3.5m and share awards ...

Astrazeneca has defended the £14.7 million pay package handed to chief executive Pascal Soriot, saying the group is too big ...

Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

The Financial Times top stories include a UK watchdog's provisional approval of a $570 million travel deal, AstraZeneca ...

Canadian VC saw $7.86 billion invested across 592 deals in 2024, per the CVCA, buoyed by later-stage megadeals while seed ...

Consultant in endocrinology and diabetes Professor Vinod Patel discusses current recommended pharmacological treatment ...